Scholars Central

Conference abstractPublished 18 Dec 2017

Endogenous sex steroid hormone levels in women with breast malignancy

Authors: Anne Wilkinson

NKP Salve Institute of Medical Sciences and Research Centre, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Hormones play a critical role in breast carcinogenesis. In the recent past there has been extensive focus on the role of estrogen as a growth regulator of normal breast tissue and breast cancer. However, progesterone is also a potent breast mitogen. Testosterone or its metabolites might play a role in breast cancer etiology by altering the availability of estrogens or by acting as an estrogen precursor. 30 cases of newly diagnosed breast cancer cases were selected of which 12 were premenopausal and 18 were postmenopausal women. Most of the cases were in the age group of 41-50 years (47%), followed by 31-40 years. 79% of the patients were presented with complaint of breast lump. Upper outer quadrant was most commonly involved followed by the upper inner quadrant. 73% of the cases were of infiltrating ductal carcinoma. Other cases included were of infiltrating lobular carcinoma, medullary carcinoma, mucinous carcinoma, apocrine carcinoma, metaplastic carcinoma, spindle cell sarcoma and malignant phyllodes. Serum endogenous sex steroid hormone levels (estradiol, progesterone and testosterone) of the 30 women with breast cancer and 40 healthy controls were analyzed using the enzyme linked immuno fluoresence assay (ELFA) method. Serum levels of estradiol were found to be raised in the premenopausal and postmenopausal phases with statistically significant association of p 0.05. Although comparable data was found in other Western studies, we do not have many studies done on the endogenous sex hormone levels in breast cancer patients in our country and the surrounding areas. Concentration of serum estradiol may predict the risk for breast malignancy and hence may help the clinicians to decide further management to decrease breast cancer risk.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Breast Cancer: Current Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBreast Cancer: Current Research
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Anne Wilkinson”